All Stories

  1. Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease

    Article • Alimentary Pharmacology & Therapeutics, September 2025, Wiley

    Douwe Postma

  2. [68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge

    Article • European Journal of Pediatrics, June 2025, Springer Science + Business Media

    Douwe Postma

  3. Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction

    Article • Transplant Infectious Disease, March 2025, Wiley

    Douwe Postma

  4. From introducing Table 0 to forgetting Figure 1: it is time for a reporting guideline for publishing with real-world clinical data—Response to de Kok et al

    Article • Journal of Clinical Epidemiology, March 2025, Elsevier

    Douwe Postma

  5. The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B

    Article • Liver International, February 2025, Wiley

    Douwe Postma

  6. Delayed Diagnosis of Disseminated Invasive Aspergillosis with Purulent Myocarditis in an Immunocompromised Host

    Article • Infectious Disease Reports, November 2024, MDPI AG

    Douwe Postma

  7. Validation of MEWS, NEWS, NEWS-2 and qSOFA for different infection foci at the emergency department, the acutelines cohort

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2024, Springer Science + Business Media

    Douwe Postma

  8. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants

    Article • Journal of Infection, October 2024, Elsevier

    Douwe Postma

  9. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study

    Article • The Lancet HIV, September 2024, Elsevier

    Douwe Postma

  10. Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation

    Article • Epidemiologia, August 2024, MDPI AG

    Douwe Postma

  11. Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial

    Article • Trials, August 2024, Springer Science + Business Media

    Douwe Postma

  12. Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study

    Article • Transplantation, July 2024, Wolters Kluwer Health

    Douwe Postma

  13. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Article • Scientific Reports, July 2024, Springer Science + Business Media

    Douwe Postma

  14. Using machine learning to improve the diagnostic accuracy of the modified Duke/ESC 2015 criteria in patients with suspected prosthetic valve endocarditis – a proof of concept study

    Article • European Journal of Pediatrics, June 2024, Springer Science + Business Media

    Douwe Postma

  15. Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

    Article • Nature Communications, May 2024, Springer Science + Business Media

    Douwe Postma

  16. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

    Article • Nature Communications, May 2024, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Douwe Postma

  17. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

    Article • Heliyon, May 2024, Elsevier

    Douwe Postma

  18. Correction to: Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department

    Article • Infection, April 2024, Springer Science + Business Media

    Douwe Postma

  19. Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department

    Article • Infection, April 2024, Springer Science + Business Media

    Douwe Postma

  20. The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study

    Article • Infection, April 2024, Springer Science + Business Media

    Douwe Postma

  21. Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants

    Article • March 2024, Cold Spring Harbor Laboratory Press

    Douwe Postma

  22. Lightweight transformers for clinical natural language processing

    Article • Natural Language Engineering, January 2024, Cambridge University Press

    Douwe Postma

  23. Circulating monocytes expressing senescence‐associated features are enriched in COVID‐19 patients with severe disease

    Article • Aging Cell, November 2023, Wiley

    Douwe Postma

  24. Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study

    Article • Journal of Critical Care, October 2023, Elsevier

    Douwe Postma

  25. Liver injury in hospitalized patients with COVID-19: An International observational cohort study

    Article • PLOS One, September 2023, PLOS

    Douwe Postma

  26. Distinct COVID-19 vaccine combinations result in divergent immune responses

    Article • August 2023, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Douwe Postma

  27. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

    Article • The Lancet Infectious Diseases, August 2023, Elsevier

    Douwe Postma

  28. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

    Article • Kidney International Reports, August 2023, Elsevier

    Douwe Postma

  29. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

    Article • Research and Practice in Thrombosis and Haemostasis, July 2023, Elsevier

    Douwe Postma, Aquiles Rodrigo Henriquez-Trujillo

  30. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial

    Article • Clinical Microbiology and Infection, June 2023, Elsevier

    Douwe Postma

  31. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease

    Article • Journal of Clinical Microbiology, May 2023, ASM Journals

    Douwe Postma

  32. Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID‐19 cohort

    Article • Artificial Organs, May 2023, Wiley

    Douwe Postma

  33. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

    Article • Journal of Hepatology, May 2023, Elsevier

    Douwe Postma

  34. Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

    Article • Clinical Infectious Diseases, March 2023, Oxford University Press (OUP)

    Douwe Postma

  35. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    Article • International Journal of Epidemiology, February 2023, Oxford University Press (OUP)

    Douwe Postma, Aquiles Rodrigo Henriquez-Trujillo

  36. Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

    Article • iScience, January 2023, Elsevier

    Douwe Postma

  37. Evaluation of bivalent Omicron BA.1 booster vaccination after different priming regimens in healthcare workers (SWITCH ON): a randomized controlled trial

    Article • December 2022, Cold Spring Harbor Laboratory Press

    Douwe Postma

  38. Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol

    Article • Frontiers in Immunology, November 2022, Frontiers

    Douwe Postma

  39. Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

    Article • Critical Care, September 2022, Springer Science + Business Media

    Douwe Postma

  40. Neurological manifestations of COVID-19 in adults and children

    Article • Brain, September 2022, Oxford University Press (OUP)

    Douwe Postma

  41. Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients

    Article • PLOS One, August 2022, PLOS

    Douwe Postma

  42. Outpatient convalescent plasma therapy for high-risk patients with early COVID-19. A randomized placebo-controlled trial

    Article • Clinical Microbiology and Infection, August 2022, Elsevier

    Professor (Associate) Bart L. Haagmans, Douwe Postma

  43. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Article • Scientific Data, July 2022, Springer Science + Business Media

    Douwe Postma, Aquiles Rodrigo Henriquez-Trujillo

  44. Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study

    Article • Clinical Infectious Diseases, July 2022, Oxford University Press (OUP)

    Douwe Postma

  45. Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination

    Article • July 2022, Cold Spring Harbor Laboratory Press

    Douwe Postma

  46. Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers

    Article • Clinical Infectious Diseases, July 2022, Oxford University Press (OUP)

    Douwe Postma

  47. Screening for asymptomatic deep vein thrombosis in COVID-19 patients admitted to the medical ward: a cross-sectional study

    Article • Journal of Ultrasound, May 2022, Springer Science + Business Media

    Douwe Postma

  48. Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

    Article • Nature Communications, May 2022, Springer Science + Business Media

    Douwe Postma, Dr Josep Vidal-Alaball

  49. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2022, New England Journal of Medicine (NEJM/MMS)

    Douwe Postma

  50. A highly virulent variant of HIV-1 circulating in the Netherlands

    Article • Science, February 2022, American Association for the Advancement of Science

    Douwe Postma

  51. Convalescent plasma for outpatients with early COVID-19

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Douwe Postma

  52. The value of open-source clinical science in pandemic response: lessons from ISARIC

    Article • The Lancet Infectious Diseases, December 2021, Elsevier

    Dr Jordi Riera, Douwe Postma

  53. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort

    Article • eLife, November 2021, eLife

    Aquiles Rodrigo Henriquez-Trujillo, Douwe Postma

  54. Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming

    Article • October 2021, Cold Spring Harbor Laboratory Press

    Douwe Postma

  55. Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

    Article • Frontiers in Immunology, September 2021, Frontiers

    Douwe Postma

  56. Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19

    Article • September 2021, Cold Spring Harbor Laboratory Press

    Douwe Postma

  57. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

    Article • Infection, June 2021, Springer Science + Business Media

    Prof. Antonio Sousa-Uva, Aquiles Rodrigo Henriquez-Trujillo, Douwe Postma, Dr maria gabriela oliveira fernandes

  58. Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

    Article • International Journal of Infectious Diseases, February 2021, Elsevier

    Douwe Postma

  59. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

    Article • The Lancet HIV, February 2021, Elsevier

    Douwe Postma

  60. Timely Administration of Tocilizumab Improves Survival of Hospitalized COVID-19 Patients

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Douwe Postma

  61. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Douwe Postma

  62. COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Douwe Postma

  63. ISARIC COVID-19 Clinical Data Report: Final report January 2020 – January 2023

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Douwe Postma

  64. The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis

    Article • European Journal of Pediatrics, June 2020, Springer Science + Business Media

    Douwe Postma

  65. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial

    Article • BMC Infectious Diseases, January 2019, Springer Science + Business Media

    Douwe Postma

  66. Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions

    Article • Drugs & Aging, April 2018, Springer Science + Business Media

    Douwe Postma

  67. Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to compare strategies to optimize antibiotic use

    Article • Clinical Microbiology and Infection, December 2017, Elsevier

    Douwe Postma

  68. Blood glucose levels and mortality in community-acquired pneumonia?

    Article • European Respiratory Journal, October 2017, European Respiratory Society (ERS)

    Douwe Postma

  69. Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients

    Article • Clinical Microbiology and Infection, October 2017, Elsevier

    Jordi Carratalà, Douwe Postma

  70. The Times They Are A-Changin’: Time-Dependent Exposures and Time-Dependent Confounders

    Article • Clinical Infectious Diseases, August 2017, Oxford University Press (OUP)

    Douwe Postma

  71. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy

    Article • Respiratory Medicine, August 2017, Elsevier

    Douwe Postma

  72. Community-acquired pneumonia requiring hospitalization

    Article • Current Opinion in Pulmonary Medicine, May 2017, Wolters Kluwer Health

    Douwe Postma

  73. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial

    Article • February 2017, Cold Spring Harbor Laboratory Press

    Douwe Postma

  74. Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to analyze antibiotic stewardship interventions

    Article • February 2017, Cold Spring Harbor Laboratory Press

    Douwe Postma

  75. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial

    Article • BMC Infectious Diseases, January 2017, Springer Science + Business Media

    Douwe Postma

  76. Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia

    Article • PLOS One, November 2015, PLOS

    Douwe Postma

  77. Antibiotics for Community-Acquired Pneumonia in Adults

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2015, New England Journal of Medicine (NEJM/MMS)

    Douwe Postma

  78. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics

    Article • Clinical Microbiology and Infection, August 2015, Elsevier

    Douwe Postma

  79. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

    Article • European Respiratory Journal, July 2015, European Respiratory Society (ERS)

    Douwe Postma

  80. Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2015, New England Journal of Medicine (NEJM/MMS)

    Douwe Postma

  81. Predicting Community-Acquired Pneumonia Etiology

    Article • CHEST Journal, December 2013, Elsevier

    Douwe Postma

  82. Observed Mortality Reduction in Patients Hospitalized with Community-acquired Pneumonia May Well Be Confounded by Disease Severity

    Article • The American Journal of Medicine, November 2013, Elsevier

    Douwe Postma

  83. The immunomodulatory effects of statins in community-acquired pneumonia: A systematic review

    Article • Journal of Infection, August 2013, Elsevier

    Douwe Postma

  84. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP

    Article • European Respiratory Journal, May 2012, European Respiratory Society (ERS)

    Douwe Postma

  85. Effects of Chlorhexidine Oral Decontamination on Respiratory Colonization during Mechanical Ventilation in Intensive Care Unit Patients

    Article • Infection Control, May 2012, Cambridge University Press

    Douwe Postma

  86. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding

    Article • European Journal of Internal Medicine, April 2012, Elsevier

    Douwe Postma